medRxivGenetic & Genomic MedicinePreprint
Multi-Ancestry Genome-Wide Association Meta-Analysis Identifies Novel Loci in Atopic Dermatitis
Meritxell OlivaiD, Mrinal K. SarkariD, Michael MarchiD, Amir Hossein SaeidianiD, Frank D. MentchiD, Chen-Lin HsiehiD, Fanying TangiD, Ranjitha UppalaiD, Matthew T. PatrickiD, Qinmengge LiiD, Rachael Wasikowski, Joanne Michelle KahlenbergiD, Deborah J. WatsoniD, Joseph GlessneriD, Lam C. TsoiiD, Hakon H. HakonarsoniD, Johann Eli GudjonssoniD, Kathleen M. SmithiD, Bridget M. Riley-GillisiD
Abstract
Atopic dermatitis (AD) is a highly heritable and common inflammatory skin condition affecting children and adults worldwide. Multi-ancestry approaches to AD genetic association studies are poised to boost power to detect genetic signal and identify ancestry-specific loci contributing to AD risk. Here, we present a multi-ancestry GWAS meta-analysis of twelve AD cohorts from five ancestral populations totaling 56,146 cases and 602,280 controls. We report 101 genomic loci associated with AD, including 15 loci that have not been previously associated with AD or eczema. Fine-mapping, QTL colocalization, and cell-type enrichment analyses identified genes and cell types implicated in AD pathophysiology. Functional analyses in keratinocytes provide evidence for genes that could play a role in AD through epidermal barrier function. Our study provides new insights into the etiology of AD by harnessing multiple genetic and functional approaches to unveil the mechanisms by which AD-associated variants impact genes and cell types. Disclosure StatementBRG, MO, CH, KMS are employees of AbbVie. FT was an employee of AbbVie at the time of the study. JEG (University of Michigan) has received research support from AbbVie, Janssen, Almirall, Prometheus Biosciences/Merck, BMS/Celgene, Boehringer Ingelheim, Galderma, Eli Lilly, and advisor to Sanofi, Eli Lilly, Galderma, BMS, Boehringer Ingelheim. MKS, RU, MTP, QL, RW, JMK, LCT are employees of University of Michigan and have no funding to disclose. MEM, AHS, FDM, DW, JTG, HH are employees of the Childrens Hospital of Philadelphia and no funding to disclose. The design, study conduct, and financial support for this research were provided by AbbVie. AbbVie participated in the interpretation of data, review, and approval of the publication.
- organism: human
- assay: GWAS summary statistics
- research focus: GWAS / association mapping
- approach: statistical model
- Citations
- 7
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Triangulating molecular evidence to prioritise candidate causal genes at established atopic dermatitis loci
Maria Sobczyk, Tom G. Richardson, … Lavinia Paternoster·Journal of Investigative DermatologyPeer-reviewed·Apr 23, 2021
- Multi-omic triangulation identifies molecular candidates of atopic dermatitis severity
Katie Watts, Matthias Hübenthal, … Lavinia Paternoster·medRxiv·Aug 4, 2025
- Transcriptome-wide analyses delineate the genetic architecture of expression variation in atopic dermatitis
Charalabos Antonatos, Dimitra Mitsoudi, … Yiannis Vasilopoulos·Human Genetics and Genomics AdvancesPeer-reviewed·Feb 26, 2025
- A genome-wide pleiotropy study between atopic dermatitis and neuropsychiatric disorders
Charalabos Antonatos, Alexandros Pontikas, … Yiannis Vasilopoulos·Human GenomicsPeer-reviewed·Jul 25, 2025
- Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies LRRC4C, LHX5-AS1 and nominates ancestry-specific loci PTPRK, GRB14, and KIAA0825 as novel risk loci for Alzheimer disease: the Alzheimer Disease Genetics Consortium
Farid Rajabli, Penelope H. Benchek, … Matthew P. Frosch·medRxiv·Jul 6, 2023
- Genome-wide association study analysis of disease severity in acne reveals novel biological insights.
Zhaohui Du, Tejaswi Iyyanki, … Clément Chatelain·medRxiv·Nov 13, 2023